Pacific Dunlop shares fall 5% on interim results
This article was originally published in Clinica
Shares of Pacific Dunlop, the Australian conglomerate troubled by Telectronics' faulty pacemaker leads, slid 5% in response to the interim results announced last week. These showed a fall in profits compared with a year earlier. Pacific Dunlop's shares closed at Aus$2.86 ($2.20) on February 15th, down 5% from the previous day. In total, the shares have fallen 30% since the lead problems first surfaced.